chr14-56296793-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021255.3(PELI2):āc.890A>Gā(p.Asn297Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N297K) has been classified as Uncertain significance.
Frequency
Consequence
NM_021255.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PELI2 | NM_021255.3 | c.890A>G | p.Asn297Ser | missense_variant | 6/6 | ENST00000267460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PELI2 | ENST00000267460.9 | c.890A>G | p.Asn297Ser | missense_variant | 6/6 | 1 | NM_021255.3 | P1 | |
PELI2 | ENST00000705193.1 | c.1061A>G | p.Asn354Ser | missense_variant | 6/6 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250706Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135502
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461822Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727200
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.890A>G (p.N297S) alteration is located in exon 6 (coding exon 6) of the PELI2 gene. This alteration results from a A to G substitution at nucleotide position 890, causing the asparagine (N) at amino acid position 297 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at